ストックスクリーナーアプリを入手
10.70
0.83%
-0.09
前日終値:
$10.79
開ける：
$10.75
24時間の取引高:
1,542
Relative Volume:
0.04
時価総額：
$253.66M
収益：
-
当期純損益:
$3.27M
株価収益率:
63.73
EPS:
0.1679
ネットキャッシュフロー:
$-647.10K
1週間 パフォーマンス:
-1.29%
1か月 パフォーマンス:
+0.00%
6か月 パフォーマンス:
+2.88%
1年 パフォーマンス:
+2.98%
1日の値動き範囲:
$10.65
$10.75
1週間の範囲:
$10.65
$10.80
52週間の値動き範囲:
$10.14
$11.59
Helix Acquisition Corp Ii Stock (HLXB) Company Profile
名前
Helix Acquisition Corp Ii
セクター
電話
857 702 0377
住所
C/O CORMORANT ASSET MANAGEMENT, LP, BOSTON
HLXB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HLXB
Helix Acquisition Corp Ii
|
10.65 | 253.66M | 0 | 3.27M | -647.10K | 0.1679 |
|
LION
Lionsgate Studios Corp
|
7.685 | 2.25B | 3.13B | 50.80M | 555.00M | 0.1772 |
|
AACT
Ares Acquisition Corporation Ii
|
11.17 | 696.88M | 0 | 16.92M | -1.35M | 0.29 |
|
ANSC
Agriculture Natural Solutions Acquisition Corp
|
10.62 | 458.10M | 0 | 1.30M | 0 | 0.0301 |
|
AAM
Aa Mission Acquisition Corp
|
10.23 | 449.41M | 0 | 0 | 0 | 0.00 |
|
EQV
Eqv Ventures Acquisition Corp
|
10.04 | 447.53M | 0 | 0 | 0 | 0.00 |
Helix Acquisition Corp Ii (HLXB) 最新ニュース
Helix Acquisition Corp. II SEC 10-K Report - TradingView
BBIOBridgebio Pharma Latest Stock News & Market Updates - StockTitan
Helix Acquisition Corp. II’s US$949 Million Business Combination with BridgeBio Oncology Therapeutics - Global Legal Chronicle
Newsroom - White & Case LLP
BridgeBio Oncology and Helix enter definitive merger agreement - MSN
BridgeBio spin-out in SPAC deal to target RAS and PI3Kα malignancies - The Pharma Letter
White & Case advises Helix Acquisition Corp. II on its US$949 million business combination with BridgeBio Oncology Therapeutics - White & Case LLP
Helix Acquisition Corp. II (HLXB) to Combine with BridgeBio Oncology in $360M Deal - SPACInsider
Helix Acquisition Corp. II Merger with BridgeBio Oncology Therapeutics - Leerink Partners
Finance Watch: BridgeBio’s Oncology Spinout Reveals Go-Public Plan - Citeline News & Insights
LZ Technology Closes $7.2 Million IPO -February 28, 2025 at 04:48 pm EST - Marketscreener.com
BridgeBio spinout to go public in SPAC deal with Helix Acquisition Corp. II - MSN
BridgeBio Oncology to Go Public in SPAC Deal Bringing $450M+ for Trio of Cancer Drugs - MedCity News
Boston SPAC picks biotech to take public - The Business Journals
Goodwin, White & Case Build BridgeBio's $949M SPAC Deal - Law360
BridgeBio oncology spinout to go public in blank-check merger - BioPharma Dive
BridgeBio Oncology Takes Unexpected SPAC Track to Public Markets in $450M Deal - BioSpace
Helix Acquisition to Merge With BridgeBio Oncology Therapeutics -February 28, 2025 at 09:37 am EST - Marketscreener.com
BridgeBio's KRAS-focused cancer spinout backs SPAC as path to Nasdaq - Fierce Biotech
BridgeBio Oncology Therapeutics and Helix Acquisition Corp. II To Merge - citybiz
BridgeBio oncology spinout to go public via combination with SPAC from Cormorant and Bihua Chen - Endpoints News
$450M Deal Powers New Cancer-Fighting Biotech: What's Inside BridgeBio's Oncology SPAC Merger? - StockTitan
Fifth Era Acquisition Corp. I (FERAU) Prices $200M IPO - SPACInsider
NewHold Investment Corp. III (NHICU) Prices $175M IPO - SPACInsider
Live Oak Acquisition Corp. V (LOKVU) Prices $200M IPO - SPACInsider
Wall Street Sentiment Positive After Nvidia Earnings, Lifting US Equity Futures Pre-Bell - Marketscreener.com
Rithm Acquisition Corp. (RAC.U) Prices $200M IPO - SPACInsider
Helix Acquisition Corp. II appoints new independent director - MSN
Blank Check Co Sichuan Hongyi Enterprise Management Co Ltd Files For IPO Of Up To $100 Mln - Marketscreener.com
Podcast: Inside the Private Markets with Nick Fusco, Founder & CEO of PM Insights - SPACInsider
EQT has sold Waystar shares for $ 393 million -February 25, 2025 at 12:34 am EST - Marketscreener.com
10 Oversold Pharma Stocks to Buy According to Analysts - Insider Monkey
Investors Await Business Activity, Home Sales Data as US Equity Futures Point to Mixed Open for Wall Street - Marketscreener.com
Wellgistics Health Prices $4 Million IPO -February 21, 2025 at 08:26 am EST - Marketscreener.com
Hyzon Motors Plans to Delist From Nasdaq -February 21, 2025 at 03:50 am EST - Marketscreener.com
BridgeBio: Strong Start For Attruby (NASDAQ:BBIO) - Seeking Alpha
12 Most Oversold Healthcare Stocks to Buy Now - Insider Monkey
Stocks Down Pre-Bell Ahead of Latest Retail Sales Report; Asia, Europe Mostly Up -February 14, 2025 at 07:12 am EST - Marketscreener.com
BridgeBio Earnings Preview: First Attruby Sales Data and Clinical Pipeline Milestones Ahead - StockTitan
Robot Consulting Files For US IPO -February 12, 2025 at 05:45 pm EST - Marketscreener.com
Helix Acquisition Corp. II Appoints Albert A. Holman, III to Board of Directors - Defense World
Capital One Financial Corp (NYSE: COF) Announces Merger Agreement with Discover Financial Services - Defense World
Equities Analysts Issue Forecasts for Equifax Q3 Earnings - Defense World
William Blair Issues Pessimistic Estimate for JKHY Earnings - Defense World
Roth Capital Has Negative Estimate for Alphabet Q3 Earnings - Defense World
Atb Cap Markets Analysts Lift Earnings Estimates for NOV - Defense World
Q3 Earnings Forecast for Ero Copper Issued By Raymond James - Defense World
Q3 EPS Estimates for Aviat Networks Reduced by Analyst - Defense World
Seaport Res Ptn Issues Optimistic Estimate for HONE Earnings - Defense World
What is Leerink Partnrs’ Estimate for ZNTL Q3 Earnings? - Defense World
Keefe, Bruyette & Woods Estimates Meritage Homes Q3 Earnings - Defense World
Helix Acquisition Corp Ii (HLXB) 財務データ
収益
当期純利益
現金流量
EPS
0.09%
0.10%
大文字化:
|
ボリューム (24 時間):